Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stiolto Respimat Effect on Fatigue in COPD
NCT02845752Phase 4Completed
- Sponsor
- The Lundquist Institute
- Start
- Mar 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by The Lundquist Institute. Started Mar 2017; status: completed.
02
Drugs
olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02845752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845752.